EphA2, which is endogenously expressed by OVCAR-8 tumor, emerged as a top resistance hit in the α-EphA2-CAR-M screen, confirming the validity of our method, as target loss prevents CAR-M recognition. This evidence concerns the gene EPHA2 and neoplasm.